Description

Global Therapeutic Area (TA) Regulatory Liaisons is a core function within Gilead's Global Regulatory Affairs (GRA) organisation and serves as a critical strategic partner across drug discovery, development, and commercial teams. Global TA Regulatory Liaisons develop regulatory strategic options and work closely with cross-functional leaders and regulatory authorities to determine appropriate pathways to obtain and maintain licensure and optimal formulary listings. These strategies are essential to securing and maintaining licensure for Gilead's medicinal products, proprietary methodologies, and technologies by managing registrations, regulatory filings, and agency communications and interactions across key markets worldwide.

Gilead's Pediatric Center of Excellence is a global hub based in Dublin, Ireland, dedicated to advancing the research and development of treatments for children living with serious diseases, including HIV, viral hepa...